<DOC>
	<DOCNO>NCT01919450</DOCNO>
	<brief_summary>The purpose study evaluate consistency quantitative peak stress myocardial blood flow myocardial blood flow reserve follow 10 second , 1 minute , 2 minute 4 minute delay begin rubidium-82 infusion post-Lexiscan ( regadenoson ) injection . It anticipate minimal difference four delay time .</brief_summary>
	<brief_title>Characterization Myocardial Blood Flow Measurements Using Lexiscan®™ ( Regadenoson ) ( Lexiscan®™ ) Rubidium-82 Myocardial Perfusion PET : A Temporal-Dependency Investigation</brief_title>
	<detailed_description />
	<mesh_term>Regadenoson</mesh_term>
	<criteria>Recent normal clinicallyindicated exercise myocardial perfusion SPECT , treadmill maximal exercise test exercise echocardiographic study No change symptom exercise study PET study Capable provide write informed consent BMI 2532 kg/m2 Diabetes mellitus Coronary Artery Calcium Score &gt; 25 Second Third Degree Atrioventricular Node Block Sinus Node Dysfunction Recent Syncope unknown etiology Left ventricular hypertrophy per ECG echocardiography Slowed circulation time Active wheeze acute asthmatic bronchospastic attack require change therapy within past 30 day . Patients experience previous hypersensitivity reaction think related Lexiscan</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PET</keyword>
	<keyword>Lexiscan</keyword>
	<keyword>Regadenoson</keyword>
	<keyword>Rubidium</keyword>
	<keyword>Blood Flow Reserve</keyword>
	<keyword>Myocardial Perfusion</keyword>
	<keyword>Quantitated Myocardial Perfusion</keyword>
</DOC>